Transgene to Present Individualized Neoantigen Therapeutic Vaccine TG4050 at World Vaccine Congress
Strasbourg, France, March 26, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotechnology firm dedicated to the design and development of virus-based immunotherapies for cancer treatment, has announced…